Results

Total Results: 918 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

901. Breast Abnormalities Update Surveillance Assessment_CER 47_Low (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests-update_surveillance.pdf
     September 01, 2012 - Is the portion of the CER that is probably or certainly out of date an issue of safety (a drug withdrawn … , blinding of the diagnostic test reader to patient history/other clinical information, and use of … evaluated only patients with non-palpable breast masses, 63 and one study evaluated only patients … Are there other factors and considerations (e.g., safety, care setting, patient preferences, ease of … Are there other factors and considerations (e.g., safety, care setting, patient preferences, ease of

902. Treatments for Schizophrenia in Adults: A Systematic (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/executive-summary-2017-schizophrenia-adult.pdf
     January 01, 2017 - goal of improving patient care. … patients. … patients with multiple comorbidities. … Efficacy and safety of individual second-generation vs. first generation antipsychotics in first-episode … Efficacy and safety of second-generation long-acting injections in schizophrenia: a meta-analysis of

903. Glaucoma-Treatment Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_surveillance.pdf
     January 01, 2013 - KQ 2: Does treatment of open-angle glaucoma improve patient-reported outcomes? … It will still be possible to compare the effectiveness of different treatments on patient-reported … Safety: Both demonstrated comparable safety and tolerability Digiuni 201214 Double-blind RCT 184 … Safety: no major complications were observed. … to 12 months postop Efficacy: SLT and ALT were equally effective Safety: 15 patients excluded for

904. Future Research Needs Document (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
     October 25, 2010 - attention on the strength and limits of evidence from research studies about the effectiveness and safety … Questionnaires of patients Decision aids and decision modeling Patient navigators Observational … Patient - understanding why more patients do not use SERMs b. … A Phase I, open label, oral, single-dose, escalating, randomized, parallel study to evaluate safety … Tamoxifen-associated vasculitis in a breast cancer patient.

905. Disposition of Comments for CER 167 Renal Masses (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_disposition-comments.pdf
     February 24, 2016 - If the emphasis is on preventing harm, then conversion to open surgery for the sake of safety from … may influence patient perception of the treatment they received. … Even a patient without CKD-Stage I or II, if young enough will experience renal functional decline over … In the case of the latter, such as a patient with limited life expectancy due to coexisting medical … If we had a patient with a 2 cm enhancing real mass that we thought had a 60% pretest probability,

906. Disposition of Comments for CER 176 Management of Gout (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
     March 15, 2016 - If a patient progresses to ‘chronic gout’, it simply indicates that the patient has been inadequately … Regarding the safety outcomes, were only these specific outcomes selected? … self reports showed that of the 30 patients only 1 patient in weight reduction group reported making … see general comments, particularly with regard to inclusion of comparative efficacy and comparative safety … Clinical efficacy and safety of successful longterm urate lowering with febuxostat of Allopurinol in

907. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - Investigators observed no new safety concerns for the implant. … Investigators observed no new safety concerns beyond what is known for the GLP-1 receptor agonist class … , two patients underwent operations for band or port complications, and one patient underwent band … The FAME Study consisted of 2 phase III pivotal trials that assessed the product’s safety and efficacy … A study of the safety and efficacy of a new treatment for diabetic macular edema.

908. Atrial-Fibrillation Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation_executive.pdf
     June 01, 2013 - Do the comparative safety and effectiveness of these therapies differ among specific patient subgroups … Do the comparative safety and effectiveness of these therapies differ among specific patient subgroups … Do the comparative safety and effectiveness of these therapies differ among specific patient subgroups … Do the comparative safety and effectiveness of these therapies differ among specific patient subgroups … Do the comparative safety and effectiveness of these therapies differ among specific patient subgroups

909. Cesarean-Birth-2010 Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cesarean-birth-2010_executive.pdf
     January 01, 2010 - large proportion of variation is not explained by some facilities having much higher or lower risk patients … is variation of the magnitude we see in use of cesarean after taking into account differences in patient … characteristics, the conclusion is that provider preferences, and to a lesser extent patient preferences … In another study, injection of hyaluronidase into the cervix in the outpatient clinic for patients … Modifications and safety evaluation would be a prerequisite to future trials.

910. Disposition of Comments Report for Strategies To Reduce Cesarean Birth in Low-Risk Women (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cesarean-birth-2010_disposition-comments.pdf
     January 01, 2010 - Perhaps this could be reworded as “provider preferences, and to a lesser extent patient preferences … Perhaps this could be reworded as “provider preferences, and to a lesser extent patient preferences… … However, when they suggest consideration of innovative means of masking patients, they might have been … TEP #2 Discussion & Conclusion Summary for KQ1 should reiterate the issues around the safety of the … There was no attempt in this study to look at VBACs rated to outcomes, safety or guideline evidence

911. Disposition of Comments for CER 161 Major Depressive Disorder (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/major-depressive-disorder-disposition-160504.pdf
     December 08, 2015 - During followup, patients initially treated with psychotherapy received no further treatment; patients … of psychotherapy because you blind the provider of a psychological treatment and the patient is an … Since these are non-psychotic patients I would think it is not so much a matter of allowing patients … of the physician’s supervision or monitoring (although the patient may elect to keep the physician … here given the implications for patient safety.

912. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/atrial-fibrillation_research-protocol.pdf
     May 22, 2012 - Do the comparative safety and effectiveness of these therapies differ among specific patient subgroups … Do the comparative safety and effectiveness of these therapies differ among specific patient subgroups … Do the comparative safety and effectiveness of these therapies differ among specific patient subgroups … Do the comparative safety and effectiveness of these therapies differ among specific patient subgroups … Does the comparative safety and effectiveness of these therapies differ among specific patient subgroups

913. Disposition of Comments Report for Core Needle and Open Surgical Biopsy for Diagnosis of Breast Lesions: An Update to the 2009 Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-update_disposition-comments.pdf
     September 10, 2014 - Various stakeholders – including patients and patient advocates, frontline clinicians, clinical researchers … As stated in the preceding row of this table, various stakeholders – including patients and patient … work-up than patients with nonpalpable lesions. … , patients on aspirin, Plavix, etc. … Will safety- net institutions take a bigger economic hit than private offices?

914. Venous-Ulcers-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_executive.pdf
     January 01, 2014 - had extensive premarket evaluation and study protocol evaluation; however, premarketing testing for safety … Key Questions Our objective was to systematically review the literature on the effectiveness and safety … by other patients. … had major problems that limited our ability to make firm conclusions about the effectiveness and safety … Efficacy and safety of the freeze-dried cultured human keratinocyte lysate, LyphoDerm 0.9%, in the

915. Cer-238-Cervical-Ripening-Appendix-E-2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-appendix-e-2.xlsx
     January 01, 2017 - 18% (9/50) vs. 10% (5/50) RR 1.80 (95% CI 0.65 to 4.99) NR Placental abruption: none reported (No patient … CR per se; Patient comparison groups from 2 diff hospitals/geographic locations; Excluded co-morbidities … Cundiff reports on 1179 patients, with a stated focus of “neonatal safety" and appears to only include … IP based on patient preference? Fewer OP vs. … , respectively. [7 patients in each group had forcep delivery.]

916. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Experts were optimistic that reductions in PN use could potentially improve patient health outcomes … Experts expected to see additional scrutiny of teduglutide’s safety and its impact on cost of care … PN reduction might significantly improve patient outcomes and quality of life. … Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal … Making 'every patient counts' a business imperative. [internet].

917. Osteoporosis-Bone-Fracture Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
     March 01, 2012 - Process In 1979, the FDA published its first Guidance Document for the clinical evaluation of the safety … Patient inclusion criteria for FDA clinical trials consisted of objective evidence of disease (i.e. … (Cramer, 2008) Adherence (or compliance) is defined as “the extent to which a patient acts in accordance … In March 2010, the FDA issued a followup to its 2007 safety review, noting the inconsistency in the … And what patient factors are important (such as the aforementioned low BMD at baseline) in terms of

918. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/musculoskeletal-complaints-tests-children_research-protocol.pdf
     September 29, 2010 - Rheumatology (ILAR)15 have developed classification criteria that are frequently used to classify patients … search strategies designed to identify evidence relevant to questions of efficacy, effectiveness and safety … As noted in the background section, patients with JIA can have symptoms of MSK pain and joint swelling … Prevalence of autoantibodies to cyclic citrullinated peptide in patients with rheumatic diseases other … A patient with undiagnosed limb pain and/or joint swelling is considered to be a patient who presents